Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis
- PMID: 17869382
- DOI: 10.1016/j.neurobiolaging.2007.07.015
Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis
Abstract
Cerebral "microvascular" disease occurs in lacunar stroke, leukoaraiosis, vascular dementia and Alzheimer's disease. It may arise from or contribute to insidious damage to the blood-brain barrier (BBB). We systematically reviewed the literature for evidence that BBB permeability is altered in patients with manifestations of cerebral microvascular disease. We found 31 BBB permeability studies (1953 individuals) of normal ageing or cerebral microvascular disease. In healthy humans, increasing age (10 comparisons, controls(C):subjects(S)=357:336) was associated with increased BBB permeability (standardised mean difference (S.M.D.) 1.21, 95% confidence interval (CI) 0.60, 1.81, p<0.01). BBB permeability was increased further in patients with either vascular or Alzheimer's dementia compared with age-matched controls (26 comparisons, C:S=510:547, S.M.D. 0.81, 99% CI 0.37, 1.26, p<0.01); in vascular compared with Alzheimer's dementia (10 comparisons, C:S=291:165, S.M.D. 0.71, 99% CI 0.12, 1.29, p<0.01); and with worsening leukoaraiosis (5 comparisons, C:S=122:88, S.M.D. 0.60, 99% CI 0.30, 0.89, p<0.01). BBB permeability increases with normal ageing and may be an important mechanism in the initiation or worsening of cerebral microvascular disease. Further studies on the role of BBB permeability are urgently needed.
Comment in
-
Is it appropriate to use albumin CSF/plasma ratio to assess blood brain barrier permeability?Neurobiol Aging. 2011 Jul;32(7):1338-9. doi: 10.1016/j.neurobiolaging.2008.08.024. Epub 2009 Aug 25. Neurobiol Aging. 2011. PMID: 19709781 No abstract available.
Similar articles
-
Nimodipine for primary degenerative, mixed and vascular dementia.Cochrane Database Syst Rev. 2001;(1):CD000147. doi: 10.1002/14651858.CD000147. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2002;(3):CD000147. doi: 10.1002/14651858.CD000147. PMID: 11279679 Updated.
-
Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12782. doi: 10.1111/nan.12782. Epub 2022 Feb 2. Neuropathol Appl Neurobiol. 2022. PMID: 34823269
-
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2. Cochrane Database Syst Rev. 2021. PMID: 35608903 Free PMC article.
-
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2. Cochrane Database Syst Rev. 2021. PMID: 34918337 Free PMC article.
-
Nimodipine for primary degenerative, mixed and vascular dementia.Cochrane Database Syst Rev. 2002;(3):CD000147. doi: 10.1002/14651858.CD000147. Cochrane Database Syst Rev. 2002. PMID: 12137606
Cited by
-
Advanced techniques using contrast media in neuroimaging.Magn Reson Imaging Clin N Am. 2012 Nov;20(4):699-713. doi: 10.1016/j.mric.2012.07.007. Epub 2012 Sep 25. Magn Reson Imaging Clin N Am. 2012. PMID: 23088946 Free PMC article. Review.
-
Cessation of neoangiogenesis in Alzheimer's disease follows amyloid-beta immunization.Sci Rep. 2013;3:1354. doi: 10.1038/srep01354. Sci Rep. 2013. PMID: 23446889 Free PMC article.
-
The Anti-Inflammatory Properties of Phytochemicals and Their Effects on Epigenetic Mechanisms Involved in TLR4/NF-κB-Mediated Inflammation.Front Immunol. 2021 Mar 26;12:606069. doi: 10.3389/fimmu.2021.606069. eCollection 2021. Front Immunol. 2021. PMID: 33868227 Free PMC article. Review.
-
T Cells-Protective or Pathogenic in Alzheimer's Disease?J Neuroimmune Pharmacol. 2015 Dec;10(4):547-60. doi: 10.1007/s11481-015-9612-2. Epub 2015 May 10. J Neuroimmune Pharmacol. 2015. PMID: 25957956 Review.
-
Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus.BMJ Open Diabetes Res Care. 2024 Jan 17;12(1):e003744. doi: 10.1136/bmjdrc-2023-003744. BMJ Open Diabetes Res Care. 2024. PMID: 38233078 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical